Novartis Ag (NVS) Return on Equity [ROE] (2009 - 2026)
Novartis Ag's Return on Equity [ROE] came in at 31.52% for Q2 2026, down 2.36 percentage points from 33.88% a year earlier and down 0.10 percentage points from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Novartis Ag's Return on Equity [ROE] was 30.81%, up 4.53 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +16.42 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 26.28% in FY2024 (-1.71 pp), 27.98% in FY2023 (+17.05 pp), 10.93% in FY2022 (-27.66 pp) and 38.59% in FY2021 (+24.20 pp).
- The five-year range for quarterly Return on Equity [ROE] is 11.56% (Q4 2022) to 41.24% (Q3 2024).
- Year-over-year, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -0.04 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2024 (a gain of 24.92 percentage points), and the weakest in Q4 2022 (a drop of 26.94 percentage points).
- Business Quant data shows NVS's Return on Equity [ROE] at 31.62% (Q1 2026), 30.60% (Q4 2025) and 33.14% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,248.18 Bn | 1,221.79 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 676.30 Bn | 596.16 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 517.93 Bn | 485.94 Bn | 13.12 Bn | - |
| 4 | Merck | 364.09 Bn | 327.03 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.96 Bn | 289.20 Bn | - | - |
| 6 | Astrazeneca | 292.99 Bn | 266.88 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 250.53 Bn | 202.18 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 209.76 Bn | 184.86 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.38 Bn | 114.74 Bn | 12.56 Bn | 4.66% |
| 10 | Vertex Pharmaceuticals | 138.91 Bn | 110.90 Bn | 2.91 Bn | 19.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.52% |
| Mar 31, 2026 | 31.62% |
| Dec 31, 2025 | 30.60% |
| Sep 30, 2025 | 33.14% |
| Jun 30, 2025 | 33.88% |
| Mar 31, 2025 | 31.15% |
| Dec 31, 2024 | 27.27% |
| Sep 30, 2024 | 41.24% |
| Jun 30, 2024 | 39.62% |
| Mar 31, 2024 | 35.25% |
| Dec 31, 2023 | 34.95% |
| Sep 30, 2023 | 17.39% |
| Jun 30, 2023 | 14.71% |
| Mar 31, 2023 | 12.60% |
| Dec 31, 2022 | 11.56% |
| Sep 30, 2022 | 35.18% |
| Jun 30, 2022 | 36.85% |
| Mar 31, 2022 | 37.33% |
| Dec 31, 2021 | 38.50% |
| Sep 30, 2021 | 17.67% |
API Access
Novartis Ag Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();